Thromb Haemost 1998; 80(06): 909-911
DOI: 10.1055/s-0037-1615387
Letters to the Editor
Schattauer GmbH

Retrospective Neuropathological Review of Prion Disease in UK Haemophilic Patients

Christine A. Lee
1   Royal Free Hospital, London
,
James W. Ironside
2   CJD Surveillance Unit, Edinburgh
,
Jeanne E. Bell
2   CJD Surveillance Unit, Edinburgh
,
Paul Giangrande
3   Haemophilia Centre, Oxford
,
Christopher Ludlam
4   Royal Infirmary, Edinburgh
,
Margaret M. Esiri
5   Radcliffe Infirmary, Oxford, UK
,
James E. McLaughlin
1   Royal Free Hospital, London
› Author Affiliations
Further Information

Publication History

Received 18 June 1998

Accepted after revision 01 September 1998

Publication Date:
07 December 2017 (online)

Preview

Summary

In 1996, the CJD surveillance unit in Edinburgh, UK described nvCJD which was thought to be the human equivalent of bovine spongiform encephalopathy (BSE). The identification of prion protein in the tonsil of an affected individual has raised the question of transmission of nvCJD via blood products. This study examines the post mortem brains of 33 patients who were treated with clotting factor concentrate of predominately UK donor source during the years 1962-1995. The brains were examined by conventional histological methods and also for the prion protein using monoclonal antibodies KG9 and 3F4. No evidence of spongiform encephalopathy was found and the immunocytochemistry was negative for PrP in all cases. It is concluded that, at present, there is no evidence for the transmission of nvCJD via clotting factor concentrate to patients with haemophilia.